Live from the NIH registry
Studies recruiting near Fairfield right now
Top 25 of 348 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Northbay Cancer Center — Vacaville, California (7.2 mi)
· Sponsor: SWOG Cancer Research Network
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Kaiser Permanente Medical Center-Vacaville — Vacaville, California (7.2 mi)
· Sponsor: NRG Oncology
Healthy Lifestyles for Bipolar Disorder
Time Restricted Eating, Diet, Mediterranean
N/A
Interventional 300 participants sought
University of California — Berkeley, California (29.7 mi)
· Sponsor: University of California, Berkeley
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Walnut Creek, California (24.4 mi)
· Sponsor: AstraZeneca
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1006 — Walnut Creek, California (24.4 mi)
· Sponsor: Immunovant Sciences GmbH
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
John Muir Physician Network Clin. Research Center — Walnut Creek, California (24.4 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
One of a Kind Clinical Research Center — Napa, California (13.9 mi)
· Sponsor: Celldex Therapeutics
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Contra Costa Regional Medical Center — Martinez, California (17.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
SELUTION4BTK Trial
Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
N/A
Interventional 376 participants sought
St. Helena Hospital — St. Helena, California (29.2 mi)
· Sponsor: M.A. Med Alliance S.A.
Alcohol-ROC-Training
Binge Drinking, Heavy Drinking
N/A
Interventional 177 participants sought
University of California, Berkeley — Berkeley, California (29.7 mi)
· Sponsor: Yale University
Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial
Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma AJCC v8
N/A
Interventional 1,000 participants sought
University of California, Davis — Davis, California (25.4 mi)
· Sponsor: OHSU Knight Cancer Institute
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Phase 3
Interventional 1,123 participants sought
John Muir Health Cancer Center ( Site 6028) — Walnut Creek, California (24.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Non-Small-Cell Lung Cancer, Metastatic Non-Small-Cell Lung Cancer
Phase 3
Interventional 480 participants sought
Kaiser Permanente Medical Center — Vallejo, California (16.1 mi)
· Sponsor: ArriVent BioPharma, Inc.
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Pneumonia
N/A
Observational 12,500 participants sought
Kaiser Permanente Walnut Creek Medical Center — Walnut Creek, California (24.4 mi)
· Sponsor: Pfizer
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Heart Failure, Cardiorenal Syndrome
N/A
Interventional 320 participants sought
John Muir Health — Concord, California (19.4 mi)
· Sponsor: Procyrion
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
John Muir Medical Center /ID# 257103 — Concord, California (19.4 mi)
· Sponsor: AbbVie
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Breast Neoplasms, Carcinoma, Ductal, Breast
N/A
Interventional 725 participants sought
Kaiser Permanente NorCal — Vallejo, California (16.1 mi)
· Sponsor: Natera, Inc.
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Local Institution - 0208 — Pleasant Hill, California (21.5 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
Sunwise Clinical Research /ID# 248529 — Walnut Creek, California (24.4 mi)
· Sponsor: AbbVie
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1007 — Walnut Creek, California (24.4 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
Macular Telangiectasia Type 2 (MacTel)
Phase 4
Interventional 234 participants sought
Bay Area Retina Associates — Walnut Creek, California (24.4 mi)
· Sponsor: Neurotech Pharmaceuticals
The SolanoConnex Trial: Evaluation of a Mental Health Access Project
Mental Health
N/A
Interventional 200 participants sought
Touro University, California — Vallejo, California (16.1 mi)
· Sponsor: Touro University, California
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
COVID-19 Vaccines
Phase 4
Interventional 200 participants sought
Diablo Clinical Research, LLC dba Flourish Research — Walnut Creek, California (24.4 mi)
· Sponsor: BioNTech SE
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Contra Costa Regional Medical Center — Martinez, California (17.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Acute Respiratory Distress Syndrome, ARDS
Phase 3
Interventional 970 participants sought
Direct Biologics Investigational Site — Davis, California (25.4 mi)
· Sponsor: Direct Biologics, LLC